Interestingly, in our research, we found that CCR2 was low‐expression in LUAD, which seemed to elucidate why CCR2 inhibitors have no cytotoxicity on the A549 human lung cancer cell line.33 This evidence concerns the gene CCR2 and lung carcinoma.